Jin Medical International Ltd.
No enriched coverage for $ZJYL in the last 7 days.
No SEC Form 4 filings for $ZJYL in the last 30 days.
See all $ZJYL insider activity →Jin Medical International (NASDAQ:ZJYL) shares jumped 63.41% to $3.17 in after-hours after it reported unaudited six-month results ended Mar. 31. Revenue fell 9.7% to $8.9M. Gross margin rose to 26.9% from 24.3%, net loss was $0.2M, and it held $9.1M cash plus $21M short-term investments.
JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) reported unaudited results for the six months ended March 31, 2026. Revenue fell 9.7% to $8.9 million. Gross margin rose to 26.9% and net loss was $0.2 million. Cash was $9.1 million plus $21.0 million short-term investments. Wheelchair revenue was stable; foreign exchange pressure from Nissin was cited.
Zhongji Innolight, a Chinese optical transceiver maker, began trading on Hong Kong’s exchange and shares fell about 5%. The company raised HK$53.4 billion (about $6.8 billion) in an IPO priced at HK$980 per share, below the HK$1,010 top of the range. It supplies AI data center and networking components and plans to fund R&D and capacity expansion.
Recent ZJYL coverage spans earnings, ipo and financial news.
After-hours jump is tied to margin improvement and component sales growth despite revenue decline and a net loss.
The print is a mixed fundamental update: top-line softness tied to FX and a key Japan customer, offset by margin improvement and higher wheelchair-component sales.
IPO pricing and first-day trading weakness suggest near-term sentiment pressure, but the disclosed use of proceeds supports longer-term capex/R&D expectations.
The draft prospectus is a fresh, time-bound catalyst for the IPO process and risk framing around U.S. exposure.
The filing indicates significant indirect ownership of Jin Medical International Ltd. by its director and CEO, Wang Erqi. While this reveals insider holdings, it does not directly influence current market valuation or trading dynamics.
alphai scores every news story that mentions ZJYL with an AI model for sentiment and relevance, and aggregates insider trades from Jin Medical International Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Jin Medical International (NASDAQ:ZJYL) shares jumped 63.41% to $3.17 in after-hours after it reported unaudited six-month results ended Mar. 31. Revenue fell 9.7% to $8.9M. Gross margin rose to 26.9% from 24.3%, net loss was $0.2M, and it held $9.1M cash plus $21M short-term investments.
4 min readJIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) reported unaudited results for the six months ended March 31, 2026. Revenue fell 9.7% to $8.9 million. Gross margin rose to 26.9% and net loss was $0.2 million. Cash was $9.1 million plus $21.0 million short-term investments. Wheelchair revenue was stable; foreign exchange pressure from Nissin was cited.
6 min readZhongji Innolight, a Chinese optical transceiver maker, began trading on Hong Kong’s exchange and shares fell about 5%. The company raised HK$53.4 billion (about $6.8 billion) in an IPO priced at HK$980 per share, below the HK$1,010 top of the range. It supplies AI data center and networking components and plans to fund R&D and capacity expansion.
3 min readChina’s Zhongji Innolight, a Shenzhen-listed maker of optical modules for AI data centers, published its post-hearing draft prospectus for a Hong Kong listing. It targets raising up to $7 billion, with bookbuilding possibly next week and debut in early August. The filing cites 61.7% U.S. revenue in Q1 and U.S. DoD adding it to a Chinese military companies list on June 8.
6 min readJin Medical International Ltd.'s director and CEO, Wang Erqi, has filed an Initial Statement of Beneficial Ownership (Form 3), disclosing his indirect ownership of 4,306,307 Class A Ordinary Shares and 1,000,000 Class B Ordinary Shares. These holdings are primarily through Jolly Harmony Enterprises Limited and Er Pu International Limited, giving him significant control over the company's equity. The filing details the structure of his beneficial ownership and the date of the event requiring the statement as March 18, 2026.
2 min readBeijing, China, July 15, 2025 ( GLOBE NEWSWIRE ) -- Jin Medical International Ltd. ( Nasdaq: ZJYL ) ( "Jin Medical", and together with all its subsidiaries, the "Company" ) , a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin ...
2 min read
